Critics of Section 936, while acknowledging that the incentive did help create new jobs in Puerto Rico, nonetheless assert that it was an "inefficient" mechanism for creating jobs. As evidence of Section 936's "inefficiency," they cite the fact that in recent years pharmaceutical employment on the island has increased "precisely when Section 936 benefits were being phased-out." What these critics fail to recognize - but what the recent GAO report on Puerto Rico confirms - is that many companies operating in Puerto Rico in this post-936 era continue to benefit from a tax incentive somewhat equivalent to Section 936 but...
